ProQR Therapeutics N.V. Insider Trades
NASDAQ: PRQRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 5 · $1.34M
- Sales
- 0 · $0
- Shares bought / sold
- 800.00K / 0
- Net activity
- Net buying $1.3 million
ProQR Therapeutics N.V. insider activity
Over the last 12 months, ProQR Therapeutics N.V. insiders reported 5 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $1.3 million and sold $0 worth of stock, for net insider buying of $1.3 million. The most recent filing shows de Boer Daniel Anton (Chief Executive Officer) buying 200,000 shares at $1.77 on Jul 31, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PRQR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PRQR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 31, 2026 | de Boer Daniel AntonChief Executive Officer | Buy | 200,000 | $353.96K | Form 4 |
| Jul 17, 2026 | Filius BartDirector | Buy | 150,000 | $257.93K | Form 4 |
| Jul 9, 2026 | de Boer Daniel AntonChief Executive Officer | Buy | 150,000 | $261.00K | Form 4 |
| Jul 7, 2026 | de Boer Daniel AntonChief Executive Officer | Buy | 150,000 | $238.50K | Form 4 |
| Jun 26, 2026 | Filius BartDirector | Buy | 150,000 | $231.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4